Is Complete Response Enough? An Expert Look Towards the Future of Higher Risk MDS Treatment

Описание к видео Is Complete Response Enough? An Expert Look Towards the Future of Higher Risk MDS Treatment

This satellite symposium discusses current key topics in higher-risk MDS, including treatment outcome measures, latest data on new agents in clinical development, and IPSS-M scoring. At the end of the discussion portion, the experts debate featured subjects in higher-risk MDS.

This satellite symposium was sponsored by Novartis

Topics in focus:

Overview of Higher-Risk MDS Key Topics in Focus
Beyond a Complete Response: Achieving Durable Outcomes for Patients With HR-MDS
Personalized Approaches to Treating HR-MDS With Novel Combinations
Debates
Question & Answer

Faculty:

Andrew Wei, MBBS, PhD
Peter MacCallum Cancer Centre and Royal Melbourne Hospital
Melbourne, Australia

Stef Meers, MD, PhD
AZ Klina
Antwerp, Belgium

Комментарии

Информация по комментариям в разработке